Año: 2024
Journal Impact Factor (JIF): 7.80
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| INFECTIOUS DISEASES | SCIE | 6/137 | Q1 | T1 | D1 |
Año: 2024
Journal Citation Indicator (JCI): 2,690
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| INFECTIOUS DISEASES | 4/137 | Q1 | T1 | D1 | 97,45 |
Año:
2024
CiteScore:
15,500
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Epidemiology | 7/158 | Q1 | T1 | D1 |
| Immunology and Microbiology (miscellaneous) | 1/38 | Q1 | T1 | D1 |
| Infectious Diseases | 15/357 | Q1 | T1 | D1 |
| Microbiology | 13/188 | Q1 | T1 | D1 |
| Microbiology (medical) | 10/148 | Q1 | T1 | D1 |
| Public Health, Environmental and Occupational Health | 11/687 | Q1 | T1 | D1 |
| Virology | 8/86 | Q1 | T1 | D1 |
SJR año:
2024
Factor de Impacto:
2,331
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Epidemiology | 13/160 | Q1 | T1 | D1 |
| Infectious Diseases | 17/361 | Q1 | T1 | D1 |
| Medicine (miscellaneous) | 115/2523 | Q1 | T1 | D1 |
| Microbiology | 17/185 | Q1 | T1 | D1 |
| Microbiology (medical) | 10/150 | Q1 | T1 | D1 |
| Public Health, Environmental and Occupational Health | 22/698 | Q1 | T1 | D1 |
| Virology | 6/86 | Q1 | T1 | D1 |
| Agencia | Código de Proyecto |
|---|---|
| EFPIA | - |
| European Union | - |
| # | Autor | Afiliación |
|---|---|---|
| 1 | Hassoun-Kheir, Nasreen | Hôpitaux universitaires de Genève (Switzerland) |
| 2 | Guedes, Mariana | Hospital Universitario Virgen Macarena; Centro Hospitalar Universitário de São João (Spain) |
| 3 | Arieti, Fabiana | Università degli Studi di Verona (Italy) |
| 4 | Pezzani, Maria Diletta | Università degli Studi di Verona (Italy) |
| 5 | Gladstone, Beryl Primrose | Universitätsklinikum Tübingen Medizinische Fakultät (Germany) |
| 6 | Robotham, Julie V. | UK Health Security Agency (United Kingdom) |
| 7 | Pouwels, Koen B. | University of Oxford Medical Sciences Division (United Kingdom) |
| 8 | Kingston, Rhys | UK Health Security Agency (United Kingdom) |
| 9 | Carmeli, Yehuda | Israel Ministry of Health (Israel) |
| 10 | Cassini, Alessandro | Centre Hospitalier Universitaire Vaudois (Switzerland) |
| 11 | Cecchini, Michele | L'Organisation de Coopération et de Développement Economiques (France) |
| 12 | Drobniewski, Francis | Imperial College London (United Kingdom) |
| 13 | Frost, Isabel | AstraZeneca (United Kingdom) |
| 14 | Geurtsen, Jeroen | Janssen Vaccines & Prevention B.V. (Netherlands) |
| 15 | Kronenberg, Andreas | University of Bern (Switzerland) |
| 16 | Htay, Mila Nu Nu | Manipal Academy of Higher Education (India) |
| 17 | Paul, Mical | Technion - Israel Institute of Technology (Israel) |
| 18 | Rocha-Pereira, Nuno | Centro Hospitalar Universitário de São João; Faculdade de Medicina da Universidade do Porto (FMUP) (Portugal) |
| 19 | Rodríguez-Baño, Jesús | Hospital Universitario Virgen Macarena; Instituto de Salud Carlos III (Spain) |
| 20 | Scudeller, Luigia | Research and Innovation Unit (Italy) |
| 21 | Stewardson, Andrew J. | Monash University (Australia) |
| 22 | Tacconelli, Evelina | Università degli Studi di Verona (Italy) |
| 23 | Harbarth, Stephan | Hôpitaux universitaires de Genève (Switzerland) |
| 24 | Vella, Venanzio | GlaxoSmithKline SpA (Italy) |
| 25 | Hôpitaux universitaires de Genève (Switzerland) |
